Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

WATCHMAN FLX Pro European Registry

NCT: NCT07262255 · ACTIVE_NOT_RECRUITING

NCT IDNCT07262255
StatusACTIVE_NOT_RECRUITING
Start Date2025-12-17
SponsorBoston Scientific Corporation (INDUSTRY)
First posted
Last updated

Brief Summary

The WATCHMAN FLX Pro European registry is intended to gather real world clinical data for patients undergoing left atrial appendage closure (LAAC) with the WATCHMAN FLX™ Pro device. In a subregistry with approximately 300 patients, it is intended to use the VersaCross Connect™ LAAC Access Solution.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑